Status:
TERMINATED
ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry
Lead Sponsor:
AlloSource
Conditions:
Cartilage Injury
Cartilage Damage
Eligibility:
All Genders
Brief Summary
The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.
Detailed Description
This multi-center, observational registry will be used to evaluate the effectiveness of ProChondrix CR in patients who undergo treatment for an articular cartilage defect in the knee, ankle, foot or h...
Eligibility Criteria
Inclusion
- Diagnosed by physician to have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention;
- Will be having, or has had, a cartilage repair procedure using ProChondrix CR;
- Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry protocol;
Exclusion
- • Is a ward of the state, prisoner, or transient.
Key Trial Info
Start Date :
January 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 14 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04301258
Start Date
January 6 2020
End Date
September 14 2023
Last Update
November 21 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern Alabama
Mobile, Alabama, United States, 36604
2
Rocky Mountain Foot and Ankle Center
Wheat Ridge, Colorado, United States, 80033
3
CAO Research Foundation
Washington D.C., District of Columbia, United States, 20037
4
University of Kentucky Research Foundation
Lexington, Kentucky, United States, 40506